BioSpace’s Lori Ellis hosts a discussion on the revival of biopharma funding, delving into the macroeconomic landscape and funding prospects. Venture capital experts Ansbert Gadicke, Martin Gershon, and Mike Goguen offer insights on the necessary factors for the resurgence of funding in the biopharma sector.
What needs to happen for funding in biopharma to bounce back? BioSpace’s Lori Ellis discuss the macroeconomic environment and biopharma funding outlook with venture capital guests Ansbert Gadicke, Martin Gershon and Mike Goguen.
Source: Bio Space